Clinical Trials Logo

Filter by:
NCT ID: NCT05593276 Completed - Depression Clinical Trials

The Preliminary Effects of Empower@Home

Start date: January 5, 2023
Phase: N/A
Study type: Interventional

This randomized pilot trial uses a waitlist control parallel design of a novel internet-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. This study will enroll approximately 35 older adults per group throughout Michigan. The intervention will take approximately ten weeks to complete. Participants will have lower levels of depression after completing the intervention than before enrollment. Participants will be able to use the internet-based platform with minimal support.

NCT ID: NCT05593211 Completed - Renal Disease Clinical Trials

Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures

Start date: October 17, 2022
Phase: N/A
Study type: Interventional

The primary objective for this study is to assess safety and performance of the Kronos Electrocautery Device for electrocautery procedures following coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc.

NCT ID: NCT05592951 Completed - Safety Clinical Trials

Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers

Start date: September 30, 2022
Phase: N/A
Study type: Interventional

The nutrient composition of this product is similar to the existing Liquid IV "hydration multiplier" product already on the market but with the addition of amino acids. With such low quantities of amino acids, in particular as compared to the amounts consumed in normal diets, there is no reason to believe that the product would cause any adverse outcomes. However, since no research has been done on the safety of regular consumption of this product, this study will evaluate the safety of the product with regards to routing blood chemistries and other variables. Specifically, standard testing will be performed including a measurement of vital signs, comprehensive metabolic panel, hematology panel, urinalysis, and quantification of triiodothyronine, thyroxine, and thyroid stimulating hormone. A questionnaire will also be used to assess product tolerability.

NCT ID: NCT05592860 Completed - Diabetes Mellitus Clinical Trials

Comparison of Glycemic Control With Smartphone Application

Start date: July 10, 2021
Phase: N/A
Study type: Interventional

The study is aimed to determine if a smartphone application based weekly glucose monitoring by a care provider is superior to the routine home glucose monitoring by patients in poorly controlled type 2 diabetes mellitus who are on insulin.

NCT ID: NCT05592561 Completed - Clinical trials for Physiological Stress

Impact of Supplements on Stress Markers

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to examine the effects of caffeine, theanine and tyrosine ingestion on markers of stress in healthy college aged individuals that are exposed to a mental stress task. The main questions to answer are: 1. what is the impact of a mental stress task involving a cognitive challenge and virtual reality based active shooter scenario on markers of subjective and biological stress? 2. what is the impact of supplement ingestion (caffeine, theanine, tyrosine, analyzed separately) 40 min prior to exposure to the mental stress task?

NCT ID: NCT05592418 Completed - Long COVID Clinical Trials

Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions

Start date: June 30, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of Ampligen® administered twice weekly by intravenous (IV) infusions in subjects experiencing the Post-COVID Condition of fatigue.

NCT ID: NCT05592340 Completed - Food Preferences Clinical Trials

Restaurant Menu Carbon Footprint Labeling

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

This online randomized clinical trial will test the effects of restaurant menu carbon footprint labels on consumers' choices and perceptions of restaurant menu items.

NCT ID: NCT05592223 Completed - Tuberculosis Clinical Trials

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Start date: December 6, 2022
Phase: Phase 1
Study type: Interventional

The purpose of the study is to develop a BCG challenge model for use in short term Phase I human trials capable of assessing the ability of TB drugs and/or vaccine-induced immune responses to impact in vivo mycobacterial replication as a method of assessing antimycobacterial agents and/or protective immunity elicited by vaccines or host-directed therapy. The trial will illuminate the nature of local and systemic immune responses to BCG and treatment response, as well as demonstrate our local capacity for newer, more innovative study designs.

NCT ID: NCT05592145 Completed - Clinical trials for Post-Op Complication

Quantifying the Venous Congestion Curve of a Tissue Oximetry Device

Start date: November 10, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to measure rate of decline and pattern of tissue oxygenation using the device, ViOptix T.Ox. ViOptix probes will be secured to the arm and hand. The recording process on the ViOptix machine will begin and obtain baseline StO2 levels for 5 minutes. After 5 minutes, a blood pressure cuff will be inflated on one arm. This blood pressure cuff will be left inflated for 10-20 minutes. Every 2 minutes a pulse check or doppler exam will be performed at your wrist. Last, the cuff will be deflated and the you will be free to leave the study room.

NCT ID: NCT05591755 Completed - Clinical trials for Seasonal Allergic Conjunctivitis

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis

Start date: November 18, 2022
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of Combo compared to its individual components and compared to vehicle in a population of subjects with seasonal allergic conjunctivitis.